Literature DB >> 8442324

Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases.

E Hellmén1, R Bergström, L Holmberg, I B Spångberg, K Hansson, A Lindgren.   

Abstract

The prognostic variables of 223 consecutively sampled spontaneous mammary tumors from female dogs were studied. These variables included flow cytometric DNA analysis and cell proliferation measured as cells in S-phase rate evaluated from DNA histograms. The dogs were surgically treated, in most cases with unilateral mastectomy (all mammary glands), and 202 of the 223 dogs were studied temporally following surgery. Univariate analysis with correction for age indicated that the variables of lymph node metastasis, elevated S-phase rate, presence of a sarcoma, DNA aneuploidy, and ulceration and infiltrative growth into underlying tissue had a statistically significant negative influence on the survival rates of dogs with a diagnosed malignant tumor. Similar results were obtained from tests on all dogs, but tumor size and its relative hazard increased with increasing size of the tumors, regardless of whether total or disease-specific mortality was considered. Using multivariate-analysis conducted Cox's proportional hazards model, elevated S-phase rate, increased age, and presence of a sarcoma remained statistically significant risk factors. The prognostic value of DNA ploidy and lymph node status varied depending on choice of end point. The study of tumor growth pattern and tumor size provided no prognostic information in the multivariate analysis. Flow cytometric cell analysis, including S-phase rate and DNA ploidy, is of value in predicting the prognosis of canine mammary tumors and can be used as a new prognostic tool to improve the preoperative diagnostics of canine mammary tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8442324     DOI: 10.1177/030098589303000103

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  14 in total

1.  Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates.

Authors:  Alessandra Estrela-Lima; Márcio S S Araújo; João M Costa-Neto; Andréa Teixeira-Carvalho; Stella M Barrouin-Melo; Sergio V Cardoso; Olindo A Martins-Filho; Rogéria Serakides; Geovanni D Cassali
Journal:  BMC Cancer       Date:  2010-06-04       Impact factor: 4.430

2.  Evaluation of adverse effects in tamoxifen exposed healthy female dogs.

Authors:  Wanessa L F Tavares; Gleidice E Lavalle; Mariana S Figueiredo; Aline G Souza; Angelica C Bertagnolli; Fernando A B Viana; Paulo R O Paes; Rubens A Carneiro; Guilherme A O Cavalcanti; Marilia M Melo; Geovanni D Cassali
Journal:  Acta Vet Scand       Date:  2010-12-22       Impact factor: 1.695

3.  Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN.

Authors:  Kaja S Borge; Silje Nord; Peter Van Loo; Ole C Lingjærde; Gjermund Gunnes; Grethe I G Alnæs; Hiroko K Solvang; Torben Lüders; Vessela N Kristensen; Anne-Lise Børresen-Dale; Frode Lingaas
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

4.  Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.

Authors:  Kiran Kumar Jagarlamudi; Sara Westberg; Henrik Rönnberg; Staffan Eriksson
Journal:  BMC Vet Res       Date:  2014-10-08       Impact factor: 2.741

5.  Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.

Authors:  M R de Araújo; L C Campos; E Ferreira; G D Cassali
Journal:  J Vet Intern Med       Date:  2015-06-30       Impact factor: 3.333

6.  Relationship among insulin resistance, growth hormone, and insulin-like growth factor I concentrations in diestrous Swedish Elkhounds.

Authors:  E M Strage; M S Lewitt; J M Hanson; U Olsson; F Norrvik; I Lilliehöök; B S Holst; T Fall
Journal:  J Vet Intern Med       Date:  2014 Mar-Apr       Impact factor: 3.333

7.  MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.

Authors:  Malgorzata Bulkowska; Agata Rybicka; Kerem Mert Senses; Katarzyna Ulewicz; Katarzyna Witt; Joanna Szymanska; Bartlomiej Taciak; Robert Klopfleisch; Eva Hellmén; Izabella Dolka; Ali O Gure; Joanna Mucha; Mariusz Mikow; Slawomir Gizinski; Magdalena Krol
Journal:  BMC Cancer       Date:  2017-11-07       Impact factor: 4.430

8.  Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study.

Authors:  Andreia A Santos; Célia C Lopes; Jorge R Ribeiro; Liliana R Martins; Joana C Santos; Irina F Amorim; Fátima Gärtner; Augusto J Matos
Journal:  BMC Vet Res       Date:  2013-01-04       Impact factor: 2.741

9.  Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2 in canine mammary gland cancer.

Authors:  Renata A Sobral; Suzana T Honda; Maria Lucia H Katayama; Helena Brentani; M Mitzi Brentani; Diogo F C Patrão; Maria Aparecida A K Folgueira
Journal:  Acta Vet Scand       Date:  2008-07-04       Impact factor: 1.695

10.  Retrospective study and immunohistochemical analysis of canine mammary sarcomas.

Authors:  Izabella Dolka; Rafał Sapierzyński; Magdalena Król
Journal:  BMC Vet Res       Date:  2013-12-09       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.